Skip to content
DrSoniaFamily Medicine Canada
← Back to Prescribing

Prescribing

SABA reliever dosing

Short-acting beta-agonist use for quick symptom relief in asthma.

Last reviewed 2026-01-05|respiratory | asthma | medication

Editorial feedback

Suggest an update

Flag outdated guidance or propose revised wording for this page. Do not include PHI or patient identifiers.

Open suggestion form

Jump to

Dosing tableContraindicationsRenal and hepatic considerationsPregnancy and lactation cautionsMonitoring checkpointsStop or escalate criteria

Dosing quick reference

Medication (generic)

Salbutamol MDI (100 mcg/puff)

Starting dose

1-2 puffs every 4-6 hours as needed

Typical titration / target

Use spacer when possible; reassess if frequent use

Monitoring / notes

Frequent use (>2 days/week) suggests inadequate control.

Contraindications

  • Avoid in known salbutamol hypersensitivity.
  • Do not rely on frequent reliever-only use as a substitute for controller optimization.
  • Reassess risk in patients with severe tachyarrhythmia or medication-triggered adverse effects.

Renal and hepatic considerations

  • Routine inhaled reliever dosing usually does not require renal or hepatic adjustment.
  • In severe comorbidity, monitor for systemic beta-agonist adverse effects when use becomes frequent.
  • Review interacting medications that may increase tachycardia or electrolyte risk.

Pregnancy and lactation cautions

  • Maintain maternal respiratory stability with individualized treatment planning in pregnancy.
  • Use the minimum effective reliever exposure while optimizing controller strategy.
  • During lactation, confirm current compatibility guidance and monitor if frequent dosing is needed.

Monitoring checkpoints

  • Teach spacer technique and inhaler priming.
  • Track reliever frequency; use above 2 days/week signals inadequate control.
  • Review action plan and when to seek urgent care.

Stop or escalate criteria

  • Escalate urgently for worsening breathlessness, poor response to reliever, or hypoxia signs.
  • Escalate controller therapy if reliever use increases.
  • Stop routine self-escalation and reassess promptly if palpitations, tremor, or chest discomfort become significant.

References